Integer Holdings Corporation (ITGR)
USD 131.5
(-3.79%)
USD 131.5
(-3.79%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.04 Billion USD | 3.3% |
| 2022 | 1 Billion USD | 12.24% |
| 2021 | 897.75 Million USD | 15.46% |
| 2020 | 777.55 Million USD | -9.52% |
| 2019 | 859.39 Million USD | -7.14% |
| 2018 | 925.5 Million USD | -42.49% |
| 2017 | 1.6 Billion USD | -6.99% |
| 2016 | 1.73 Billion USD | 0.94% |
| 2015 | 1.71 Billion USD | 814.16% |
| 2014 | 187.5 Million USD | -5.06% |
| 2013 | 197.5 Million USD | -12.38% |
| 2012 | 225.41 Million USD | -4.47% |
| 2011 | 235.95 Million USD | 6.94% |
| 2010 | 220.62 Million USD | -23.77% |
| 2009 | 289.42 Million USD | -17.99% |
| 2008 | 352.92 Million USD | 46.32% |
| 2007 | 241.19 Million USD | 41.88% |
| 2006 | 170 Million USD | -0.27% |
| 2005 | 170.46 Million USD | -0.69% |
| 2004 | 171.65 Million USD | -0.07% |
| 2003 | 171.77 Million USD | 102.09% |
| 2002 | 85 Million USD | 14.24% |
| 2001 | 74.4 Million USD | 119.04% |
| 2000 | 33.96 Million USD | -74.5% |
| 1999 | 133.21 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 1.21 Billion USD | -1.77% |
| 2024 Q1 | 1.23 Billion USD | 18.59% |
| 2024 Q3 | 1.07 Billion USD | -3.41% |
| 2023 Q3 | 1.01 Billion USD | -4.42% |
| 2023 Q1 | 1.08 Billion USD | 7.42% |
| 2023 FY | 1.04 Billion USD | 3.3% |
| 2023 Q2 | 1.06 Billion USD | -1.79% |
| 2023 Q4 | 1.04 Billion USD | 2.44% |
| 2022 Q4 | 1 Billion USD | -0.35% |
| 2022 Q1 | 904.59 Million USD | 0.76% |
| 2022 Q2 | 1.02 Billion USD | 13.02% |
| 2022 Q3 | 1.01 Billion USD | -1.08% |
| 2022 FY | 1 Billion USD | 12.24% |
| 2021 Q3 | 679.96 Million USD | -5.53% |
| 2021 Q2 | 719.77 Million USD | -2.76% |
| 2021 FY | 897.75 Million USD | 15.46% |
| 2021 Q1 | 740.18 Million USD | -4.81% |
| 2021 Q4 | 897.75 Million USD | 32.03% |
| 2020 Q4 | 777.55 Million USD | -12.28% |
| 2020 Q1 | 881.76 Million USD | 2.6% |
| 2020 Q2 | 1.01 Billion USD | 15.28% |
| 2020 Q3 | 886.42 Million USD | -12.8% |
| 2020 FY | 777.55 Million USD | -9.52% |
| 2019 FY | 859.39 Million USD | -7.14% |
| 2019 Q4 | 859.39 Million USD | -0.84% |
| 2019 Q1 | 945.41 Million USD | 2.15% |
| 2019 Q3 | 866.64 Million USD | -4.0% |
| 2019 Q2 | 902.72 Million USD | -4.52% |
| 2018 Q3 | 954.19 Million USD | -37.99% |
| 2018 FY | 925.5 Million USD | -42.49% |
| 2018 Q4 | 925.5 Million USD | -3.01% |
| 2018 Q2 | 1.53 Billion USD | -1.48% |
| 2018 Q1 | 1.56 Billion USD | -2.95% |
| 2017 Q4 | 1.6 Billion USD | -1.28% |
| 2017 Q3 | 1.62 Billion USD | -2.12% |
| 2017 Q2 | 1.66 Billion USD | -2.18% |
| 2017 FY | 1.6 Billion USD | -6.99% |
| 2017 Q1 | 1.7 Billion USD | -1.6% |
| 2016 FY | 1.73 Billion USD | 0.94% |
| 2016 Q2 | 1.75 Billion USD | -0.32% |
| 2016 Q1 | 1.76 Billion USD | 2.83% |
| 2016 Q4 | 1.73 Billion USD | -0.92% |
| 2016 Q3 | 1.74 Billion USD | -0.61% |
| 2015 Q1 | 185 Million USD | -1.33% |
| 2015 Q2 | 182.5 Million USD | -1.35% |
| 2015 FY | 1.71 Billion USD | 814.16% |
| 2015 Q3 | 180 Million USD | -1.37% |
| 2015 Q4 | 1.71 Billion USD | 852.25% |
| 2014 FY | 187.5 Million USD | -5.06% |
| 2014 Q3 | 190 Million USD | -1.3% |
| 2014 Q4 | 187.5 Million USD | -1.32% |
| 2014 Q1 | 195 Million USD | -1.27% |
| 2014 Q2 | 192.5 Million USD | -1.28% |
| 2013 Q2 | 237 Million USD | 1.72% |
| 2013 Q1 | 233 Million USD | 3.37% |
| 2013 Q3 | 210 Million USD | -11.39% |
| 2013 Q4 | 197.5 Million USD | -5.95% |
| 2013 FY | 197.5 Million USD | -12.38% |
| 2012 Q3 | 230.15 Million USD | -1.38% |
| 2012 Q1 | 238.63 Million USD | 1.14% |
| 2012 FY | 225.41 Million USD | -4.47% |
| 2012 Q4 | 225.41 Million USD | -2.06% |
| 2012 Q2 | 233.37 Million USD | -2.21% |
| 2011 FY | 235.95 Million USD | 6.94% |
| 2011 Q4 | 235.95 Million USD | 18.98% |
| 2011 Q3 | 198.3 Million USD | -3.6% |
| 2011 Q2 | 205.7 Million USD | -7.82% |
| 2011 Q1 | 223.14 Million USD | 1.14% |
| 2010 FY | 220.62 Million USD | -23.77% |
| 2010 Q1 | 291.77 Million USD | 0.81% |
| 2010 Q4 | 220.62 Million USD | -7.75% |
| 2010 Q3 | 239.15 Million USD | -9.32% |
| 2010 Q2 | 263.72 Million USD | -9.62% |
| 2009 FY | 289.42 Million USD | -17.99% |
| 2009 Q2 | 307.82 Million USD | -2.46% |
| 2009 Q3 | 296.1 Million USD | -3.81% |
| 2009 Q4 | 289.42 Million USD | -2.26% |
| 2009 Q1 | 315.58 Million USD | -10.58% |
| 2008 Q2 | 357.94 Million USD | -0.76% |
| 2008 Q1 | 360.67 Million USD | 49.53% |
| 2008 FY | 352.92 Million USD | 46.32% |
| 2008 Q4 | 352.92 Million USD | 0.17% |
| 2008 Q3 | 352.31 Million USD | -1.57% |
| 2007 Q1 | 240.11 Million USD | 41.24% |
| 2007 FY | 241.19 Million USD | 41.88% |
| 2007 Q4 | 241.19 Million USD | 0.12% |
| 2007 Q3 | 240.9 Million USD | 0.16% |
| 2007 Q2 | 240.5 Million USD | 0.16% |
| 2006 Q1 | 170.16 Million USD | -0.18% |
| 2006 FY | 170 Million USD | -0.27% |
| 2006 Q3 | 170 Million USD | 0.0% |
| 2006 Q4 | 170 Million USD | 0.0% |
| 2006 Q2 | 170 Million USD | -0.1% |
| 2005 FY | 170.46 Million USD | -0.69% |
| 2005 Q1 | 171.29 Million USD | -0.21% |
| 2005 Q2 | 171.05 Million USD | -0.14% |
| 2005 Q3 | 170.76 Million USD | -0.17% |
| 2005 Q4 | 170.46 Million USD | -0.17% |
| 2004 FY | 171.65 Million USD | -0.07% |
| 2004 Q4 | 171.65 Million USD | -0.17% |
| 2004 Q3 | 171.94 Million USD | -0.1% |
| 2004 Q2 | 172.12 Million USD | 0.37% |
| 2004 Q1 | 171.49 Million USD | -0.17% |
| 2003 Q1 | 79.5 Million USD | -6.47% |
| 2003 Q3 | 171.58 Million USD | 0.08% |
| 2003 Q2 | 171.44 Million USD | 115.65% |
| 2003 Q4 | 171.77 Million USD | 0.11% |
| 2003 FY | 171.77 Million USD | 102.09% |
| 2002 FY | 85 Million USD | 14.24% |
| 2002 Q3 | 85.75 Million USD | 20.1% |
| 2002 Q1 | 71.39 Million USD | -4.04% |
| 2002 Q2 | 71.39 Million USD | -0.0% |
| 2002 Q4 | 85 Million USD | -0.87% |
| 2001 FY | 74.4 Million USD | 119.04% |
| 2001 Q1 | 35.93 Million USD | 5.78% |
| 2001 Q2 | 80.42 Million USD | 123.84% |
| 2001 Q3 | 80.42 Million USD | -0.0% |
| 2001 Q4 | 74.4 Million USD | -7.49% |
| 2000 FY | 33.96 Million USD | -74.5% |
| 2000 Q4 | 33.96 Million USD | -73.03% |
| 2000 Q3 | 125.95 Million USD | 0.0% |
| 1999 FY | 133.21 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Abbott Laboratories | 15.87 Billion USD | 93.442% |
| Allurion Technologies Inc. | 41.85 Million USD | -2386.934% |
| Artivion, Inc. | 359.34 Million USD | -189.685% |
| Avanos Medical, Inc. | 209.1 Million USD | -397.827% |
| Butterfly Network, Inc. | 25.02 Million USD | -4059.332% |
| Butterfly Network, Inc. | 25.02 Million USD | -4059.332% |
| Bio-Rad Laboratories, Inc. | 1.4 Billion USD | 25.958% |
| Boston Scientific Corporation | 9.49 Billion USD | 89.033% |
| Perspective Therapeutics, Inc. | - USD | -Infinity% |
| CONMED Corporation | 991.25 Million USD | -5.014% |
| Edwards Lifesciences Corporation | 694.9 Million USD | -49.799% |
| Paragon 28, Inc. | 112.03 Million USD | -829.176% |
| Glaukos Corporation | 383.73 Million USD | -171.267% |
| Globus Medical, Inc. | 520.4 Million USD | -100.028% |
| Inspire Medical Systems, Inc. | 24.84 Million USD | -4089.632% |
| Medtronic plc | 26.04 Billion USD | 96.004% |
| Nevro Corp. | 221.82 Million USD | -369.265% |
| Owlet, Inc. | 15.21 Million USD | -6741.193% |
| Penumbra, Inc. | 234.34 Million USD | -344.202% |
| Vicarious Surgical Inc. | 14.83 Million USD | -6918.312% |
| Smith & Nephew plc | 3.08 Billion USD | 66.247% |
| Sonendo, Inc. | 40.35 Million USD | -2479.753% |
| STERIS plc | 3.38 Billion USD | 69.231% |
| Stryker Corporation | 12.99 Billion USD | 91.99% |
| Vapotherm, Inc. | 112.39 Million USD | -826.183% |
| Zimmer Biomet Holdings, Inc. | 5.99 Billion USD | 82.637% |